Ausgabe 1/2014
Inhalt (9 Artikel)
Darexaban (YM150), an oral direct factor Xa inhibitor, has no effect on the pharmacokinetics of digoxin
Takeshi Kadokura, Dorien Groenendaal, Marten Heeringa, Roelof Mol, Frank Verheggen, Alberto Garcia-Hernandez, Hartmut Onkels
Pharmacokinetic interaction of enrofloxacin/trimethoprim combination following single-dose intraperitoneal and oral administration in rats
Myung-Jin Choi, Sileshi Belew Yohannes, Seung-Jin Lee, Dereje Damte, Jong-Choon Kim, Joo-Won Suh, Seung-Chun Park
Effect of natural borneol on the pharmacokinetics and distribution of nimodipine in mice
Chun Wu, Qiongfeng Liao, Meicun Yao, Xinjun Xu, Yuting Zhou, Xueying Hou, Zhiyong Xie
Increased elimination of paclitaxel by magnesium isoglycyrrhizinate in epithelial ovarian cancer patients treated with paclitaxel plus cisplatin: a pilot clinical study
Kai Jie Chen, Wan Yi Chen, Xia Chen, Yi Ming Jia, Gui Qin Peng, Li Chen
Integration of preclinical and clinical knowledge to predict intravenous PK in human: Bilastine case study
Valvanera Vozmediano, Ignacio Ortega, John C. Lukas, Ana Gonzalo, Monica Rodriguez, Maria Luisa Lucero
The effect of mirabegron, a potent and selective β3-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol
Walter Krauwinkel, James Dickinson, Marloes Schaddelee, John Meijer, Reiner Tretter, Jeroen van de Wetering, Gregory Strabach, Marcel van Gelderen
Effect of chronic hypoxic hypoxia on oxidation and glucuronidation of carvedilol in rats
Shizuka Yamaura, Miki Fukao, Kazuya Ishida, Masato Taguchi, Yukiya Hashimoto
Enhanced bioavailability of orally administered flurbiprofen by combined use of hydroxypropyl-cyclodextrin and poly(alkyl-cyanoacrylate) nanoparticles
Xiaoyun Zhao, Wei Li, Qiuhua Luo, Xiangrong Zhang
A clinical pharmacokinetic study comparing two azelastine hydrochloride nasal formulations in a single-dose design
Daniel Du, Darren Targett, Erhard Stolberg, Alessandra Canali